Prospera Financial Services’s Allena Pharmaceuticals ALNA Stock Holding History

Prospera Financial Services’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,800	Closed	-$2K	–	1682
2022 Q2	$2K	Buy	10,800 +5,250	+95%	+$813	﹤0.01%	1583
2022 Q1	$1K	Buy	+5,550	New	+$2.3K	﹤0.01%	2734

Other funds holding ALNA

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Prospera Financial Services's ALNA Position: Q3 2022 in Review

Prospera Financial Services sold out of Allena Pharmaceuticals (ALNA) in Q3 2022, closing a stake of 10,800 shares — an estimated $2K sold.

Prospera Financial Services first reported a position in ALNA in Q1 2022 and held it in 2 quarters. The position peaked at $2K in Q2 2022. 2 funds tracked by Wall St. Rank hold ALNA as of Q3 2022.

Prospera Financial Services reported no remaining Allena Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Prospera Financial Services sold 10,800 Allena Pharmaceuticals shares in Q3 2022, an estimated $2K.
Prospera Financial Services first reported a position in Allena Pharmaceuticals in Q1 2022 and held it in 2 quarters.
Prospera Financial Services's Allena Pharmaceuticals position peaked at $2K in Q2 2022.
2 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2022.

Based on Prospera Financial Services's 13F filing for Q3 2022, filed 27 Oct 2022.